Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY900014 vs insulin lispro in adults with type 1 diabetes
CTR20190260Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin lispro in diabetes mellitus type 1 (T1D), sponsored by Eli Lilly and Company. Started Apr 2019; status: completed.
02
Drugs
insulin lispro
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on CTR20190260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190260.